The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
To assess the efficacy and toxicity profile in patients with recurrent ovarian or primary peritoneal cancer treated with topotecan at 2.5 mg/m 2 days 1 and 8 plus vinorelbine at 25 mg/m 2 days 1 and 8 every 3 weeks.Eligibility criteria included patients with recurrent primary peritoneal or epithelial ovarian cancer with either platinum-resistant or platinum-sensitive disease. Patients...
To assess the efficacy and toxicity profile in patients treated with topotecan at 2.0 mg/m 2 /day×3 days every 3 weeks.Eligibility criteria included patients with recurrent primary peritoneal or epithelial ovarian cancer with ≥6 months elapsed from time of prior platinum treatment. Patients were required to have a performance status of ≤2 and normal hepatic and renal function. Response to...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.